Funding profile · At-home diagnostics

Scanwell Health

A venture backed diagnostics company that never filed a Form D, disclosed $3.5 million of equity and took $1.6 million from the NIH, then sold to Becton Dickinson in December 2021 at a price that has never been broken out.

Data as of September 23, 2026. Company-reported figures are labeled.

Rounds at a glance

What the filings show

Reading the filings

1. No Form D was ever filed.A Y Combinator company that raised institutional money from Founders Fund, Mayfield and DCM left no Regulation D paper trail at all. EDGAR returns no company by this name. That is legal and common for rounds sold under Section 4(a)(2), but it means every equity figure here comes from the company rather than from a filing.
2. The only price on the record is a combined one.BD reported $415 million of acquisition cash for the quarter and named three targets in the same sentence: Scanwell, Tissuemed and Venclose. Divided evenly that is about $138 million each, which no one should treat as the answer. The fiscal 2022 annual report adds MedKeeper to the same grouping, so even the denominator is soft.
3. Federal money was about a third of the total.$1,603,081 from NIEHS against $3.5 million of announced equity and $120,000 from Y Combinator gives roughly $5.22 million of identified funding, of which 31 percent was non-dilutive. The grant was for a chronic kidney disease test, not for the product that was selling.
4. The seed round was the last one announced.From November 2019 to the December 2021 sale, no further raise was announced. The February 2021 BD collaboration, then the August 2021 authorization, then the purchase, occupy the space where a Series A would normally sit.
5. The clearance that anchors the value belongs to someone else.510(k) K170118, the over-the-counter smartphone urinalysis clearance, is filed under Teco Diagnostics of Anaheim, the founder’s family firm, and the 510(k) summary states that the four underlying patents are held by Teco. No clearance exists under the Scanwell name.
6. The entity has outlived the product.The BD Veritor At-Home test lost its authorization in June 2023, yet Scanwell Health, Inc. still appears in BD’s fiscal 2025 subsidiary exhibit and then moves to Augusta SpinCo, and so to Waters, in February 2026.

Commercial signals

What to watch

• Whether Waters Corporation says anything about the platform it inherited in February 2026.
• Any change of applicant on 510(k) K170118, which would move the clearance to the corporate owner.
• A new 510(k) or emergency use authorization naming Scanwell or its app.
• A first Form D, which would only appear if the entity ever raises outside capital again.

The Scanwell Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

• Modern Health: Shared investor: Founders Fund. An employer-bought mental health benefit that sorts staff into coaching, therapy or self-guided content
• Scanbase: Shared investor: Liquid 2. An API that turns a phone photo of a rapid diagnostic test into a result, sold to the companies that make and ship the tests
• Notable Labs: Shared investor: Founders Fund. A blood cancer company that screened drugs against a patient’s own cells to predict who would respond, in-licensed a shelved Boehringer Ingelheim compound, reached
• Instalab: Shared investor: Liquid 2. A New York concierge service that lets people order their own blood work, imaging and screenings, with a network of physicians authorizing the orders behind the scenes

Sources

1. Public recordBecton Dickinson Form 10-Q, quarter ended Dec 31, 2021SEC · Feb 3, 2022
2. Public recordBecton Dickinson Form 10-K, fiscal 2022 and fiscal 2025 subsidiary exhibitsSEC
3. Public recordExhibit 21.1, Augusta SpinCo Corporation subsidiariesSEC · Dec 19, 2025
4. Public recordEDGAR company and full text search for ScanwellSEC · Accessed Sep 23, 2026
5. Public recordNIH RePORTER R44ES032768NIEHS · FY2020 and FY2021
6. Public recordFDA 510(k) letter and summary, K170118FDA · Sep 21, 2017
7. Public recordRevocation of Eleven Emergency Use AuthorizationsFederal Register · Oct 5, 2023
8. IndependentScanwell launches home smartphone test for UTIsFierce Biotech · Nov 2019
9. IndependentA startup’s struggle to make the first home antibody testBusiness Insider · Apr 2020
10. CompanyScanwell Health Announces Nationwide Launch with Lemonaid HealthBusiness Wire · Nov 4, 2019
11. CompanyBD Acquires Scanwell Health, Inc.BD · Dec 21, 2021
12. CompanyBD Completes Combination with WatersBD · Feb 9, 2026

Compiled from SEC, NIH and FDA public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; no such notice was filed by this company, so equity figures here are company-reported. Healthcare Venture Capital Fund holds no position in Scanwell Health. This page is not an offer to sell or a recommendation to buy any security.